513 results on '"Nannini, Margherita"'
Search Results
2. Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour
3. Familial adenomatosis polyposis–related desmoid tumours treated with low-dose chemotherapy: results from an international, multi-institutional, retrospective analysis
4. Metabolic pseudoprogression in a patient with metastatic KIT exon 11 GIST after 1 month of first-line imatinib: a case report
5. Genomic Landscape Comparison of Cardiac versus Extra-Cardiac Angiosarcomas
6. Preclinical Models of Visceral Sarcomas
7. An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor
8. Gene duplication, rather than epigenetic changes, drives FGF4 overexpression in KIT/PDGFRA/SDH/RAS-P WT GIST
9. Primary malignant pericardial tumour in Lynch syndrome
10. KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study
11. 68Ga-PSMA-PET vs 18F-FDG-PET in metastatic radio-refractory differentiated thyroid cancers
12. List of Contributors
13. Personalized Medicine in Gastrointestinal Stromal Tumors
14. Molecular modelling evaluation of exon 18 His845_Asn848delinsPro PDGFRα mutation in a metastatic GIST patient responding to imatinib
15. KIT/PDGFRA Variant Allele Frequency as Prognostic Factor in Gastrointestinal Stromal Tumors (GISTs): Results From a Multi-Institutional Cohort Study.
16. Data from Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
17. Revised supplementary Figure 1 from Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
18. Revised supplementary Figure 2 from Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
19. Revised supplementary Table 1 from Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
20. Revised supplementary Table 4 from Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
21. Revised supplementary Table 2 from Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
22. Revised supplementary Table 3 from Genome-Wide Analysis Identifies MEN1 and MAX Mutations and a Neuroendocrine-Like Molecular Heterogeneity in Quadruple WT GIST
23. Supplementary Data from Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study
24. SDHA Germline Mutations in SDH-Deficient GISTs: A Current Update
25. Expanding the Spectrum of BRAF Non-V600E Mutations in Thyroid Nodules: Evidence-Based Data from a Tertiary Referral Centre
26. Metabolic pseudo-progression in a patient with metastatic KIT exon 11 GIST after one month of first-line imatinib: a case report
27. An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure
28. Genomic Characterization of Rare Primary Cardiac Sarcoma Entities
29. Case report: Dramatic response to pralsetinib in an elderly patient with advanced RET-fusion positive papillary thyroid carcinoma
30. SRF Rearrangements in Soft Tissue Tumors with Muscle Differentiation
31. The right drug for the right patient at the right time with the right test in differentiated thyroid cancer (DTC)
32. Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report
33. miRNA Expression May Have Implications for Immunotherapy in PDGFRA Mutant GISTs
34. Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy
35. Thoracic myopericytoma in an older adult, rare but possible: A case report
36. Analysis of microbiome in gastrointestinal stromal tumors: Looking for different players in tumorigenesis and novel therapeutic options
37. Proposal of a molecular testing algorithm for differentiated thyroid cancer (DTC).
38. Impact of stimulated thyroglobulin and BRAF status in Stage I and ATA intermediate risk DTC
39. Are BRAF-TERT mutated differentiated thyroid cancers similar to other double mutated?
40. Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations: Results from a Multi-institutional European Retrospective Study
41. Adjuvant Imatinib in Patients with GIST Harboring Exon 9 KIT Mutations:Results from a Multi-institutional European Retrospective Study
42. The Follow-up After Radical Surgery of Colorectal Cancer: Is it Time for a “Tailored” Strategy?
43. 18F-Fluorodeoxyglucose Uptake in PDGFRA-Mutant Gastrointestinal Stromal Tumors.
44. A molecular portrait of gastrointestinal stromal tumors: an integrative analysis of gene expression profiling and high-resolution genomic copy number
45. Combined treatment strategies in gastrointestinal stromal tumors (GISTs) after imatinib and sunitinib therapy
46. SDHA Germline Variants in Adult Patients With SDHA-Mutant Gastrointestinal Stromal Tumor
47. Uterine Preservation Treatments in Sarcomas: Oncological Problems and Reproductive Results: A Systematic Review
48. Radiomics and Artificial Intelligence in Uterine Sarcomas: A Systematic Review
49. An immunohistochemical study of potential diagnostic and therapeutic biomarkers of wild-type gastrointestinal stromal tumours
50. Gene expression profiling in colorectal cancer using microarray technologies: Results and perspectives
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.